Gamunex-c 40 gram/400 ML vial 400ML
Ended Awarded
- Contract number
- SPE2DB25FY3UL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $55,853
Award facts
- Contract value 100% obligated
- $55,852.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $55,852.80 to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Gamunex-C, a 40 gram/400 milliliter immunoglobulin product. This firm fixed price delivery order, with an ultimate completion date of May 15, 2025, represents a non-competitive award and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a total value of $999,999,999.00 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly supporting Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. As a for-profit organization registered in SAM.gov, the company maintains an extensive portfolio of medical product deliveries covering multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies. This award demonstrates the contractor's continued capability to meet federal procurement requirements and support military healthcare supply chains through the DLA's pharmaceutical prime vendor program.
Quick answers
Who was awarded contract SPE2DB25FY3UL?
SPE2DB25FY3UL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on April 24, 2025.
How much is contract SPE2DB25FY3UL worth?
The government has obligated $55,853 on SPE2DB25FY3UL.
Is contract SPE2DB25FY3UL an order under another contract?
Yes. SPE2DB25FY3UL is a delivery order under SPE2DB22D3301, an indefinite delivery contract.
Was contract SPE2DB25FY3UL competed?
The extent of competition for SPE2DB25FY3UL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award